Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines - 25/05/16
Abstract |
Objectives |
To analyze inflammatory markers, adipokines, and hepatokines in obese adolescents with and without type 2 diabetes mellitus (T2DM).
Study design |
We studied high sensitivity C-reactive protein (hsCRP), tumor necrosis factor (TNF)-α, interleukin-1β, and interferon-γ, the hepatokines (fetuin-A and fibroblast growth factor [FGF]-21), and the adipokines (adiponectin and leptin) in a cross-sectional study of 74 predominately Caucasian adolescents with T2DM aged 12-18 years and in 74 body mass index (BMI)-, age–, and sex-matched controls.
Results |
Adolescents with T2DM had significantly higher concentrations of hsCRP, TNF-α, and interleukin-1β compared with obese controls without T2DM. Interferon-γ was not detectable in obese adolescents with or without T2DM. In multiple linear regression analysis, hsCRP was significantly associated with FGF-21 and BMI, but not with hemoglobin A1c, adiponectin, leptin, fetuin-A, sex, or age. TNF-α was significantly related negatively to leptin, positively to BMI, but not to hemoglobin A1c, adiponectin, fetuin-A, FGF-21 sex, or age in multiple linear regression analysis.
Conclusions |
Increased inflammatory markers are associated with T2DM in adolescents. Because hsCRP was related to FGF-21 and TNF-α was associated with leptin, these findings suggest a link between increased levels of these adipokines and hepatokines and chronic inflammation. Future longitudinal studies in humans are necessary to confirm these hypotheses.
Le texte complet de cet article est disponible en PDF.Keywords : hsCRP, TNFalpha, fetuin, FGF21, leptin, adiponectin, obesity, adolescents, type 2 diabetes mellitus
Abbreviations : BMI, CRP, FGF, Hb, hsCRP, IFN, IL, T2DM, TNF
Plan
Supported by the German Ministry of Education and Research within the German Competence Net Diabetes Mellitus (01 GI 1106), which is integrated into the German Center for Diabetes Research as of January 2015; the European Foundation for the Study of Diabetes; and the German Competence Net Obesity (01 GI 1130). The authors declare no conflicts of interest. |
Vol 173
P. 131-135 - juin 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?